Nemaura Medical to Present at the H.C. Wainwright Global Hybrid Investment Conference
19 mai 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, May 19, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
MySugarWatch Continues Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor Commencing Direct-to-Consumer Campaign in Daily Mail
17 mai 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, May 17, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
MySugarWatch Launches Physician-Focused Ads in MIMS As Part of Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor
03 mai 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, May 03, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical to Present at the Planet MicroCap Showcase 2022
25 avr. 2022 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, April 25, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference
24 mars 2022 16h24 HE
|
Nemaura Medical, Inc
Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical Wins Innovation Awards
28 févr. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update
14 févr. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches Metabolic Health Program for Employers and Insurers
13 janv. 2022 08h30 HE
|
Nemaura Medical, Inc
Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)...
Nemaura Medical Appoints Dr. Arash Ghadar as Chief Operating Officer
10 janv. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
07 janv. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...